It is possible that Robert F. Kennedy Jr. or Kyle Diamantas could overrule career employees.
hedged in the source
No event time was recorded for this claim — the text gave nothing to anchor it to, and a guessed date would be worse than none.
Standing
lens: Evidence-weighted Structural
No belief has been computed for this claim under Structural yet.
What bears on it
Nothing supports or challenges this claim yet — untested, which is not the same as refuted.
Voices
- STAT independent hedged
Voices are counted, never weighed. How many people say a thing is structure worth seeing; it is not, by itself, a reason to believe it.
What the documents actually said
The verbatim text each extraction read before resolving it into this canonical claim. Quoted, never republished.
- It is possible that Robert F. Kennedy Jr. or Kyle Diamantas could overrule career employees.
But given Kennedy’s interest in the matter and the Trump administration’s propensity to allow politics to influence science, it is possible that he or acting FDA commissioner Kyle Diamantas could overrule career employees.
Sources
Who and what it involves
Origin: extracted from FDA advisory panel narrowly rejects compounding of one peptide, backs two others · 2026-09-11 07:34